Home / TORNTPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TORNTPHARM.NS make money? Does TORNTPHARM.NS have pricing power? What's the Earnings Whisper? Will TORNTPHARM.NS profit more as the business scales? What is TORNTPHARM.NS's management track record? Is TORNTPHARM.NS's current price justified?

Torrent Pharmaceuticals Limited

₹4558.9 +$710.50 (+18.46%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹4584.1

Day Range

₹4550.4₹4618.9

Year Range

₹3532.6₹5250

Market Cap

1.73T

AVG Volume

507.15K

Trailing/Forward PE

70.75/48.73

PEG ratio

-20.15

Dividend Yield

0.83%

Next Earnings Date

2026-10-23

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

TORNTPHARM.NS Revenue (INR) by year
Period	Revenue (INR)
2026	138.22B
2025	113.17B
2024	105.62B
2023	94.64B
2022	84.19B
2021	78.86B
2020	77.8B
2019	74.62B
2018	58.39B
2017	57.13B

Net Income (INR) · A

TORNTPHARM.NS Net Income (INR) by year
Period	Net Income (INR)
2026	21.63B
2025	19.11B
2024	16.56B
2023	12.54B
2022	7.77B
2021	12.52B
2020	10.25B
2019	4.36B
2018	6.78B
2017	9.34B

Operating Income (INR) · A

TORNTPHARM.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	34.4B
2025	29.26B
2024	19.48B
2023	21.4B
2022	17.69B
2021	18.28B
2020	15.19B
2019	13.69B
2018	9.82B
2017	11.75B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Torrent Pharmaceuticals Limited

Video analysis: TORNTPHARM.NS

News: TORNTPHARM.NS

Similar companies